Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Takeda, from which it is licensing its preclinical drugs.
Author: Robert Lavine
Uhouzz opens its doors to $14m
The interational student housing services startup almost doubled its total funding in a series B round backed by New Oriental Education Group.
Danone helps stock Farmers Fridge with $10m
The food producer’s corporate venture capital unit joined Powerplant Ventures and Cleveland Avenue to invest in the healhy vending machine supplier.
Kona Deep drinks in $5.5m
Danone Manifesto Ventures has invested in bottled ocean water brand Kona Deep in its fifth deal since launching in September last year.
The Wing takes flight with $32m
WeWork led the female networking organisation’s series B round, closed in advance of the opening of two more of its branches.
NS8 plays nice to secure $7.5m
The Bloomberg-backed e-commerce fraud prevention software startup has raised money in an Arbor Ventures-led round.
Pixvana picks corporates for $14m round
Microsoft Ventures, Cisco Investments and Hearst Ventures have contributed to Pixvana’s Vulcan Capital-led series B round.
Arsanis closes IPO at $46m
The monoclonal antibody developer, which counts GV and EMBL Ventures among its investors, had initially raised $40m when it floated last week.
Corporates go to SeedCamp for fourth fund
The Europe-focused VC firm has raised more than $54m from LPs including Unilever Ventures, Thomas Cook Money and MassMutual Ventures.
Divergent 3D produces series B funding
The vehicle manufacturing technology developer has raised $65m+ in an Altran-backed round that could eventually close at $107m.
Syapse reaches Ascension to raise $25m
Ascension Ventures led the precision medicine technology provider’s series C round, which included Social Capital Partnership and Safeguard Scientifics.
De Beers to mine startups through CVC unit
De Beers Ventures will target companies operating in areas such as consumer brands, marketing, imaging technology, and jewel cutting and polishing.
Axios stacks up $20m in funding
The short-form media platform has tripled its total funding, raising cash from investors including NBCUniversal and WndrCo.
SCPharmaceuticals gets cash injection from IPO
Sun Pharmaceutical and Lundbeck scored exits in an $89.6m initial public offering by the subcutaneous heart failure therapy developer.